import { environment } from './environments/environment';

export const serverApiUrl = environment.serverApiUrl;
export const devApiUrl = 'http://localhost:3000';


export const COUNTRY_LIST_DATA = [
  'ARGENTINA',
  'AUSTRIA',
  'BELGIUM',
  'BRAZIL',
  'BULGARIA',
  'CANADA FEDERAL',
  'CANADA QUEBEC',
  'CANADA-ONTARIO',
  'CHILE',
  'CHINA',
  'COLOMBIA',
  'CROATIA',
  'CYPRUS',
  'CZECH REPUBLIC',
  'DENMARK',
  'EGYPT',
  'ENGLAND',
  'ESTONIA',
  'FINLAND',
  'FRANCE',
  'GERMANY',
  'GREECE',
  'HONG KONG',
  'HUNGARY',
  'ICELAND',
  'INDIA',
  'IRELAND',
  'ISRAEL',
  'ITALY',
  'JAPAN',
  'KUWAIT',
  'LATVIA',
  'LIECHTENSTEIN',
  'LITHUANIA',
  'LUXEMBOURG',
  'MALAYSIA',
  'MEXICO',
  'NETHERLANDS',
  'NEW ZEALAND',
  'NORWAY',
  'POLAND',
  'PORTUGAL',
  'ROMANIA',
  'RUSSIA',
  'SAUDI ARABIA',
  'SCOTLAND',
  'SINGAPORE',
  'SLOVAKIA',
  'SLOVENIA',
  'SOUTH AFRICA',
  'SOUTH KOREA',
  'SPAIN',
  'SWEDEN',
  'SWITZERLAND',
  'TAIWAN',
  'THAILAND',
  'TUNISIA',
  'TURKEY',
  'UAE',
  'UKRAINE',
  'UNITED KINGDOM',
  'USA',
];
export const BRANDS_LIST_DATA = [
  'ALPHANATE',
  'ALVEOFACT',
  'GLUTRIL',
  'GUTRON',
  'HBVAXPRO 40',
  'HCGSUGE',
  'HEFIYA',
  'HEMANGIOL',
  'HEPTRIS',
  'HIB TITER',
  'HIRUDOID',
  'HIZENTRA',
  'HUMAN INSUNORM',
  'PREVDUO',
  'PRONESTYL',
  'PROTAFAN',
  'PROVENTIL HFA',
  'PURIVIST',
  'PYZCHIVA',
  'QUADRACEL',
  'ANTISERUM',
  'AQYNZIO',
  'ARFLEYDA',
  'GOLIMUMAB',
  'GONAL F',
  'GREEN VIII',
  'GVOKE HYPOPEN',
  'HEMOFIL M',
  'HEPATITIS B HUMAN IMMUNOGLOBULIN',
  'HEPLISAV-B',
  'HUMALOG MIX 25 KWIKPEN',
  'HUMAN HEPATITIS B IMMUNE GLOBULIN',
  'HYGROTON',
  'POLHUMIN MIX 5',
  'POLHUMIN R',
  'POLYGAM',
  'PRECEDEX',
  'PRODICA',
  'PROSCAR',
  'PROSTAN',
  'PROTHIADEN',
  'PUBERGEN NANO',
  'QINLOCK',
  'QUADRAMET',
  'ABASAGLAR',
  'ABCIXIREL',
  'ABILIFY MYCITE',
  'ABLYSINOL',
  'ABSTRAL',
  'ACTEMRA',
  'ADLARITY',
  'ADYNOVATE',
  'ADYNOVI',
  'AG-B 20',
  'AGGS',
  'ALBURX 25%',
  'ALBUSOL 20%',
  'ALECENSA',
  'FLUZAK',
  'FML',
  'FOLTRAN',
  'FOSAMAX PLUS',
  'FUCIDIN 2%',
  'FUROSCIX',
  'GAMMA HEP',
  'GLIBENECK',
  'GLIBENESE',
  'GLIVEC',
  'RABIES IMMUNOGLOBULIN',
  'RAPILYSIN',
  'RINLIZ MIX 25',
  'ALAWAY',
  'ALBUMEN 10%',
  'ALBUMIN 0.03%',
  'ALBUPRIME',
  'ALBUTEIN 25%',
  'FLYRCADO',
  'FML NEO LIQUIFILM',
  'FORZATEN',
  'FUNGUSTATIN',
  'FYMSKINA',
  'GAMASTAN',
  'GEMATE P',
  'GENVOYA',
  'GLOTIB',
  'QUOFENIX',
  'RECARBRIO',
  'RECOMBIVAX HB',
  'RENVELA',
  'RETINA',
  'REZDIFFRA',
  'RHOPRESSA',
  'RIFALDIN',
];
export const INN_LIST_DATA = [
  'ENZALUTAMIDE',
  'ZONISAMIDE',
  'PEMETREXED',
  'BUPROPION',
  'RALTITREXED',
  'LENALIDOMIDE',
  'MEBENDAZOLE',
  'INTERFERON BETA-1A',
  'DISOPYRAMIDE',
  'FAMPRIDINE',
  'METFORMIN & PIOGLITAZONE',
  'TEMOZOLOMIDE',
  'BASILIXIMAB',
  'EFLORNITHINE',
  'ATEZOLIZUMAB',
  'DIACEREIN',
  'CABOZANTINIB',
  'BEROTRALSTAT',
  'AMLODIPINE & HYDROCHLOROTHIAZIDE & OLMESARTAN MEDOXOMIL',
  'AZELAIC ACID',
  'GOLIMUMAB',
  'SAQUINAVIR',
  'PREDNISOLONE',
  'GEMFIBROZIL',
  'REGORAFENIB',
  'DYDROGESTERONE',
  'PRUCALOPRIDE',
  'LETROZOLE',
  'TREOSULFAN',
  'CARIPRAZINE',
  'SULTAMICILLIN',
  'INDACATEROL',
  'CIPROFLOXACIN & FLUOCINOLONE ACETONIDE',
  'AZILSARTAN MEDOXOMIL',
  'METFORMIN & SAXAGLIPTIN',
  'VINPOCETINE',
  'LEVOCARNITINE',
  'BISACODYL',
  'INEBILIZUMAB',
  'FARICIMAB',
  'CENTRUROIDES IMMUNE F(AB)2',
  'FENOLDOPAM',
  'NALOXEGOL',
  'AVIPTADIL & PHENTOLAMINE',
  'PIVMECILLINAM',
  'NIRSEVIMAB',
  'POTASSIUM CLORAZEPATE',
  'CRISABOROLE',
  'PHENETICILLIN',
  'RABIES IMMUNOGLOBULIN',
  'RADIUM (223RA) DICHLORIDE',
  'RANITIDINE',
  'VAMOROLONE',
  'ZOONOTIC INFLUENZA VACCINE (H5N1)',
  'FIBRINOGEN, HUMAN',
  'METHYLDOPA (LEVOROTATORY)',
  'ENFUVIRTIDE',
  'NAPROXEN & SUMATRIPTAN',
  'FUSIDIC ACID',
  'NIVOLUMAB',
  'MEASLES, COMBINATIONS WITH MUMPS AND RUBELLA, LIVE ATTENUATED',
  'MORPHINE',
  'SOMATOSTATIN',
  'TRIAMCINOLONE',
  'CALCITRIOL',
  'PERTUSSIS, PURIFIED ANTIGEN, COMBINATIONS WITH TOXOIDS',
  'CILASTATIN & IMIPENEM & RELEBACTAM',
  'HYDROCHLOROTHIAZIDE & LISINOPRIL',
  'ABACAVIR & LAMIVUDINE',
  'BECLOMETASONE & FORMOTEROL',
  'TRAZODONE',
  'DABIGATRAN ETEXILATE',
  'GUANFACINE',
];

export const TABLE_DATA = [
  {
    country_name: 'AUSTRIA',
    brand_name: 'ZOVIRAX',
    inn: 'ACICLOVIR',
    moa: 'Deoxyribonucleic Acid (DNA) Polymerase Inhibitor',
    pack_description: 'ZOVIRAX ORAL SUSPENSION 8000 MG 100 ML 1 BOTTLE',
    company_name: 'GLAXOSMITHKLINE',
    brand_category: 'BRANDED',
    therapy_class_name: 'ANTIVIRALS FOR SYSTEMIC USE',
    whoatc_name: 'J05AB01',
    orphan_status: false,
    price_start_date: '2021-03-01T00:00:00.000Z',
    currency_name: 'EUR',
    hospital_price: null,
    exfactory_price: 35.54,
    ppp: 39.27,
    pp_inc_vat: 55.2889876,
    reimbursed_classification: 'REIMBURSED',
    reimbursable_price: 55.28,
    copayment_price: null,
    source_update_date: '2024-09-27T00:00:00.000Z',
  },
  {
    country_name: 'AUSTRIA',
    brand_name: 'ZOVIRAX',
    inn: 'ACICLOVIR',
    moa: 'Deoxyribonucleic Acid (DNA) Polymerase Inhibitor',
    pack_description: 'ZOVIRAX TABLETS 200 MG 25 TABS 1 PACK',
    company_name: 'GLAXOSMITHKLINE',
    brand_category: 'BRANDED',
    therapy_class_name: 'ANTIVIRALS FOR SYSTEMIC USE',
    whoatc_name: 'J05AB01',
    orphan_status: false,
    price_start_date: '2016-01-01T00:00:00.000Z',
    currency_name: 'EUR',
    hospital_price: null,
    exfactory_price: 16.5,
    ppp: 18.23,
    pp_inc_vat: 27.066768,
    reimbursed_classification: 'REIMBURSED',
    reimbursable_price: 27.06,
    copayment_price: null,
    source_update_date: '2024-09-27T00:00:00.000Z',
  },
  {
    country_name: 'AUSTRIA',
    brand_name: 'ZOVIRAX',
    inn: 'ACICLOVIR',
    moa: 'Deoxyribonucleic Acid (DNA) Polymerase Inhibitor',
    pack_description: 'ZOVIRAX TABLETS 800 MG 35 TABS 1 PACK',
    company_name: 'GLAXOSMITHKLINE',
    brand_category: 'BRANDED',
    therapy_class_name: 'ANTIVIRALS FOR SYSTEMIC USE',
    whoatc_name: 'J05AB01',
    orphan_status: false,
    price_start_date: '2016-01-01T00:00:00.000Z',
    currency_name: 'EUR',
    hospital_price: null,
    exfactory_price: 62.79,
    ppp: 68.13,
    pp_inc_vat: 92.188978,
    reimbursed_classification: 'REIMBURSED',
    reimbursable_price: 92.18,
    copayment_price: null,
    source_update_date: '2024-09-27T00:00:00.000Z',
  },
  {
    country_name: 'AUSTRIA',
    brand_name: 'ZOVIRAX',
    inn: 'ACICLOVIR',
    moa: 'Deoxyribonucleic Acid (DNA) Polymerase Inhibitor',
    pack_description: 'ZOVIRAX INFUSION 250 MG 10 ML 5 POWDER VIAL',
    company_name: 'GLAXOSMITHKLINE',
    brand_category: 'BRANDED',
    therapy_class_name: 'ANTIVIRALS FOR SYSTEMIC USE',
    whoatc_name: 'J05AB01',
    orphan_status: false,
    price_start_date: '2016-01-01T00:00:00.000Z',
    currency_name: 'EUR',
    hospital_price: null,
    exfactory_price: 77.76,
    ppp: 85.92,
    pp_inc_vat: 145.6599999,
    reimbursed_classification: 'NON REIMBURSED',
    reimbursable_price: null,
    copayment_price: 145.65,
    source_update_date: '2024-09-27T00:00:00.000Z',
  },
  {
    country_name: 'BELGIUM',
    brand_name: 'ZOVIRAX',
    inn: 'ACICLOVIR',
    moa: 'Deoxyribonucleic Acid (DNA) Polymerase Inhibitor',
    pack_description: 'ZOVIRAX INJECTION 250 MG 10 ML 5 POWDER VIAL',
    company_name: 'GLAXOSMITHKLINE',
    brand_category: 'BRANDED',
    therapy_class_name: 'ANTIVIRALS FOR SYSTEMIC USE',
    whoatc_name: 'J05AB01',
    orphan_status: false,
    price_start_date: '2022-10-01T00:00:00.000Z',
    currency_name: 'EUR',
    hospital_price: null,
    exfactory_price: 9.55,
    ppp: 10.8,
    pp_inc_vat: 15.886567,
    reimbursed_classification: 'NON REIMBURSED',
    reimbursable_price: null,
    copayment_price: 15,
    source_update_date: '2024-10-16T00:00:00.000Z',
  },
];

export const STEPS = [
  'Select topic',
  'Select package',
  'Filter & preview data',
  'Purchase report',
  'Download & explore',
];

export const TOPICS_1 = [
  {
    title: 'Pricing',
    cardTitle: 'Pricing',
    coverage: [
      'No. of Countries: 63',
      'Data Type: Branded & Biosimilar',
      'Data History: Latest Price Only',
      'No. of Data Endpoints: 20',
    ],
    buttonLabel: 'Grab a topic',
    linkLabel: 'View Details',
    isSelected: false,
    details: [
      {
        field: 'Country',
        field_description: 'Name of the country',
      },
      {
        field: 'Brand name',
        field_description: 'Standardized Brand Name',
      },
      {
        field: 'INN',
        field_description: 'Active Ingredient',
      },
      {
        field: 'MOA',
        field_description: 'Mechanism of Action',
      },
      {
        field: 'Pack description',
        field_description:
          'Brand name + Formulation + Strength + Strength unit + Fill size + Fill unit + Pack Size + Pack Unit',
      },
      {
        field: 'Company',
        field_description: 'Standardized Company Name',
      },
      {
        field: 'Brand Category',
        field_description: 'Brand Type (Branded, Biosimilar)',
      },
      {
        field: 'Therapy Class',
        field_description: 'Therapeutic Area',
      },
      {
        field: 'WHOATC',
        field_description: 'Alphanumeric Code Published By WHO',
      },
      {
        field: 'Orphan Status',
        field_description:
          'Orphan Drug Designation (Yes Or No) applicable to specific region',
      },
      {
        field: 'Price Start Date',
        field_description: 'Price Effective Date',
      },
      {
        field: 'Currency',
        field_description: 'Standard Currency Code',
      },
      {
        field: 'Ex Factory',
        field_description: 'Manufacturer Price Excluding VAT',
      },
      {
        field: 'Hospital',
        field_description: 'Purchasing Price for Hospitals',
      },
      {
        field: 'PPP',
        field_description:
          'Pharmacy Purchase Price Without VAT / Wholesaler price',
      },
      {
        field: 'PP Inc Vat',
        field_description: 'Public Price Including VAT / Retail price with VAT',
      },
      {
        field: 'Formulary Reimbursement Classification',
        field_description:
          'Pack-level Reimbursement Status (Reimbursed, Reimbursed with Restrictions, Not Reimbursed)',
      },
      {
        field: 'Reimbursement Price',
        field_description:
          'Price at pack level to be reimbursed by statutory mechanisms; according to level of reimbursement',
      },
      {
        field: 'Co-pay Price',
        field_description:
          'Out of pocket pack level price to be paid by the customer/patient',
      },
      {
        field: 'Source Update Date',
        field_description:
          'Publication date of the latest information on country source',
      },
    ],
  },
  
  {
    title: 'Market Access',
    cardTitle: 'Market Access',
    coverage: [
      'No. of Countries: 31',
      'Data Type: Branded & Biosimilar',
      'No. of Data Endpoints: 21',
    ],
    buttonLabel: 'Grab a topic',
    linkLabel: 'View Details',
    isSelected: false,
    details: [
      {
        field: 'Country',
        field_description: 'Name of the country',
      },
      {
        field: 'Brand name',
        field_description: 'Standardized Brand Name',
      },
      {
        field: 'INN',
        field_description: 'Active Ingredient',
      },
      {
        field: 'MOA',
        field_description: 'Mechanism of Action',
      },
      {
        field: 'Pack description',
        field_description:
          'Brand name + Formulation + Strength + Strength unit + Fill size + Fill unit + Pack Size + Pack Unit',
      },
      {
        field: 'Company',
        field_description: 'Standardized Company Name',
      },
      {
        field: 'Brand Category',
        field_description: 'Brand Type (Branded, Biosimilar)',
      },
      {
        field: 'Therapy Class',
        field_description: 'Therapeutic Area',
      },
      {
        field: 'WHOATC',
        field_description: 'Alphanumeric Code Published By WHO',
      },
      {
        field: 'Orphan Status',
        field_description:
          'Orphan Drug Designation (Yes Or No) applicable to specific region',
      },
      {
        field: 'Top Level Indication',
        field_description:
          'A unique form or finest form of indication. Every indication has unique TLI',
      },
      {
        field: 'Regulatory Indication',
        field_description:
          'Indication approved by regulatory authority of a country and is extracted as mentioned in regulatory label with all key information as patient population, any restrictions etc. with proper grammatical sense and complete details (especially for those captured after translation)',
      },
      {
        field: 'Indication HTA',
        field_description:
          'The indication for which the HTA body issued a recommendation. It specifies which condition the drug is recommended or not recommended to treat, and may also specify which age group is recommended to treat',
      },
      {
        field: 'National HTA Body',
        field_description:
          'Abbreviation of the HTA body corresponding to the particular country',
      },
      {
        field: 'Assessment Publication Date',
        field_description: 'Date when the decision was issued',
      },
      {
        field: 'Local Decision',
        field_description:
          'Recommendation or Not Recommendation of reimbursement of a medicine for a particular indication (HTA)',
      },
      {
        field: 'Standardised Decision',
        field_description:
          'There are 3 possible decisions: Recommended, Restricted Recommended, or Not Recommended (for reimbursement)',
      },
      {
        field: 'Clinical Reason',
        field_description:
          'Clinical reason behind the decision of the HTA body',
      },
      {
        field: 'Economic Reason',
        field_description: 'If the assessed drug has value for money',
      },
      {
        field: 'Comparator',
        field_description:
          'The drug that is used for comparison in the Clinical and/or Economical Analysis',
      },
      {
        field: 'Utilisation Restrictions',
        field_description:
          'If the drug will be used with restrictions (Example: to be used only for 2 years)',
      },
    ],
  },
  {
    title: 'Treatment Cost',
    cardTitle: 'Treatment Cost',
    coverage: [
      'No. of Countries: 63',
      'Data Type: Branded & Biosimilar',
      'No. of Data Endpoints: 18',
    ],
    buttonLabel: 'Grab a topic',
    linkLabel: 'View Details',
    isSelected: false,
    details: [
      {
        field: 'Country',
        field_description: 'Name of the country',
      },
      {
        field: 'Brand name',
        field_description: 'Standardized Brand Name',
      },
      {
        field: 'INN',
        field_description: 'Active Ingredient',
      },
      {
        field: 'MOA',
        field_description: 'Mechanism of Action',
      },
      {
        field: 'Pack description',
        field_description:
          'Brand name + Formulation + Strength + Strength unit + Fill size + Fill unit + Pack Size + Pack Unit',
      },
      {
        field: 'Company',
        field_description: 'Standardized Company Name',
      },
      {
        field: 'Brand Category',
        field_description: 'Brand Type (Branded, Biosimilar)',
      },
      {
        field: 'Therapy Class',
        field_description: 'Therapeutic Area',
      },
      {
        field: 'WHOATC',
        field_description: 'Alphanumeric Code Published By WHO',
      },
      {
        field: 'Orphan Status',
        field_description:
          'Orphan Drug Designation (Yes Or No) applicable to specific region',
      },
      {
        field: 'Top Level Indication',
        field_description:
          'A unique form or finest form of indication. Every indication has unique TLI',
      },
      {
        field: 'Regulatory Indication',
        field_description:
          'Indication approved by regulatory authority of a country and is extracted as mentioned in regulatory label with all key information as patient population, any restrictions etc. with proper grammatical sense and complete details (especially for those captured after translation)',
      },
      {
        field: 'Currency',
        field_description: 'Standard Currency Code',
      },
      {
        field: 'Pack Price',
        field_description:
          'Price of pack as a whole, it is equal to a particular price level (Ex factory/Hospital Price/Pharmacy Purchase Price Without VAT)',
      },
      {
        field: 'Per Day (Including Wastage)',
        field_description:
          'Cost of treatment for a particular indication for one day including wastage',
      },
      {
        field: 'Per Month (Including Wastage)',
        field_description:
          'Cost of treatment for a particular indication for one month including wastage',
      },
      {
        field: 'Per Annum (Including Wastage)',
        field_description:
          'Cost of treatment for a particular indication for one year including wastage',
      },
      {
        field: 'Per Duration (Including Wastage)',
        field_description:
          'Cost of treatment for a particular indication for a particular duration including wastage which is less than or more than one year',
      },
    ],
  },
];

export const TOPICS_2 = [
  {
    title: 'Dosing',
    cardTitle: 'Dosing Assumptions',
    coverage: [
      'No. of Countries: 63',
      'Data Type: Branded & Biosimilar',
      'No. of Data Endpoints: 20',
    ],
    buttonLabel: 'Grab a topic',
    linkLabel: 'View Details',
    isSelected: false,
    details: [
      {
        field: 'Country',
        field_description: 'Name of the country',
      },
      {
        field: 'Brand name',
        field_description: 'Standardized Brand Name',
      },
      {
        field: 'INN',
        field_description: 'Active Ingredient',
      },
      {
        field: 'MOA',
        field_description: 'Mechanism of Action',
      },
      {
        field: 'Pack description',
        field_description:
          'Brand name + Formulation + Strength + Strength unit + Fill size + Fill unit + Pack Size + Pack Unit',
      },
      {
        field: 'Company',
        field_description: 'Standardized Company Name',
      },
      {
        field: 'Brand Category',
        field_description: 'Brand Type (Branded, Biosimilar)',
      },
      {
        field: 'Therapy Class',
        field_description: 'Therapeutic Area',
      },
      {
        field: 'WHOATC',
        field_description: 'Alphanumeric Code Published By WHO',
      },
      {
        field: 'Orphan Status',
        field_description:
          'Orphan Drug Designation (Yes Or No) applicable to specific region',
      },
      {
        field: 'Top Level Indication',
        field_description:
          'A unique form or finest form of indication. Every indication has unique TLI',
      },
      {
        field: 'Regulatory Indication',
        field_description:
          'Indication approved by regulatory authority of a country and is extracted as mentioned in regulatory label with all key information as patient population, any restrictions etc. with proper grammatical sense and complete details (especially for those captured after translation)',
      },
      {
        field: 'Loading Dosing',
        field_description:
          'Initial higher dose of a drug that may be given at the beginning of a course of treatment before dropping down to a lower maintenance dose',
      },
      {
        field: 'Maintenance Dosing',
        field_description:
          'Steady and constant dose given with only one dosing frequency',
      },
      {
        field: 'Loading Dosing Frequency',
        field_description: 'Frequency at which loading dose is administered',
      },
      {
        field: 'Loading Dosing Frequency Unit',
        field_description:
          'Unit for loading dose frequency e.g. day, week, month or year',
      },
      {
        field: 'Maintenance Dosing Frequency',
        field_description:
          'Frequency at which maintenance dose is administered',
      },
      {
        field: 'Maintenance Dosing Frequency Unit',
        field_description:
          'Unit for maintenance dose frequency e.g. day, week, month or year',
      },
      {
        field: 'Loading Dosing Duration',
        field_description:
          'Time from the start of first loading dose to switching on to maintenance therapy',
      },
      {
        field: 'Loading Dosing Duration Unit',
        field_description:
          'Unit for loading dose duration e.g. day, week, month or year',
      },
      {
        field: 'Maintenance Dosing Duration',
        field_description: 'Time to continue therapy at maintenance dose',
      },
      {
        field: 'Maintenance Dosing Duration Unit',
        field_description:
          'Unit for maintenance dose duration e.g. day, week, month or year',
      },
      {
        field: 'Body Surface Area',
        field_description:
          'When drug dose depends upon body surface area of patient, body surface area in meters squared is populated',
      },
      {
        field: 'Average Weight',
        field_description:
          'When drug dose depends upon body weight of patient, average body weight in kilograms is populated',
      },
    ],
  },
  {
    title: 'Regulatory Approvals',
    cardTitle: 'Regulatory Approvals',
    coverage: [
      'No. of Countries: 63',
      'Data Type: Branded & Biosimilar',
      'No. of Data Endpoints: 15',
    ],
    buttonLabel: 'Grab a topic',
    linkLabel: 'View Details',
    isSelected: false,
    details: [
      {
        field: 'Country',
        field_description: 'Name of the country',
      },
      {
        field: 'Brand name',
        field_description: 'Standardized Brand Name',
      },
      {
        field: 'INN',
        field_description: 'Active Ingredient',
      },
      {
        field: 'MOA',
        field_description: 'Mechanism of Action',
      },
      {
        field: 'Pack description',
        field_description:
          'Brand name + Formulation + Strength + Strength unit + Fill size + Fill unit + Pack Size + Pack Unit',
      },
      {
        field: 'Company',
        field_description: 'Standardized Company Name',
      },
      {
        field: 'Brand Category',
        field_description: 'Brand Type (Branded, Biosimilar)',
      },
      {
        field: 'Therapy Class',
        field_description: 'Therapeutic Area',
      },
      {
        field: 'WHOATC',
        field_description: 'Alphanumeric Code Published By WHO',
      },
      {
        field: 'Orphan Status',
        field_description:
          'Orphan Drug Designation (Yes Or No) applicable to specific region',
      },
      {
        field: 'Top Level Indication',
        field_description:
          'A unique form or finest form of indication. Every indication has unique TLI',
      },
      {
        field: 'Regulatory Indication',
        field_description:
          'Indication approved by regulatory authority of a country and is extracted as mentioned in regulatory label with all key information as patient population, any restrictions etc. with proper grammatical sense and complete details (especially for those captured after translation)',
      },
      {
        field: 'Line Of Therapy',
        field_description:
          'Line of therapy expresses the sequence of therapies a patient undergoes',
      },
      {
        field: 'Regulatory Agency',
        field_description:
          'Regulatory authorities responsible for approval of drugs in that country (mainly written abbreviated forms)',
      },
      {
        field: 'Indication Approval Date',
        field_description:
          'Date on which regulatory authority approved the respective indication for the brand',
      },
    ],
  },
];

export const PRICING_PLANS = [
  {
    title: 'Basic Access',
    price: 249,
    features: [
      'For 1 ATC or Indication across 7 key countries.',
      'Covers only: EU4, UK, USA and Japan',
    ],
    buttonText: 'Get Started',
    isSelected: false,
  },
  {
    title: 'Enhanced Access',
    price: 849,
    features: [
      'For 1 ATC or Indication across 63 countries.',
      'Note: Only 31 countries available for Market Access',
    ],
    buttonText: 'Get Started',
    highlight: 'Most Popular',
    isSelected: false,
  },
  {
    title: 'Custom Report',
    price: '3,999',
    features: [
      'The custom report compares 3-5 drugs on pricing, HTA decisions and dosing.',
      'PowerPoint visuals accompanied by a relevant narrative.',
    ],
    buttonText: 'Talk to Team',
    isSelected: false,
  },
  {
    title: 'Consultation',
    price: '299',
    features: [
      'A virtual one-hour expert consultation on HTA decision, drug pricing or dosing.',
    ],
    buttonText: 'Talk to Team',
    isSelected: false,
  },
];
